The QuickStart Study will establish and evaluate the integration of hepatitis C testing and treatment into drug and alcohol clinics. We aim to evaluate the effect of rapid testing on treatment uptake and reduction the burden of hepatitis C in the community. We hypothesise that with increased testing, rapid testing will lead to increased treatment uptake and cure, which will have long term public health benefits.
|Effective start/end date||1/01/20 → 31/12/22|
- hepatitis C infection
- diagnostic algorithms
- injecting drug use